Tony Chung, CEO of Instant NanoBiosensors (INB), was invited by the National Biotechnology Research Park (NBRP) to give a talk on: “How FOPPR technology can assist customers in developing ultra-sensitive assays through affinity and epitope binning analysis.”

INB's FOPPR technology for affinity and epitope binning analysis can improve the accuracy, reproducibility, and efficiency of ultra-sensitive assays. A tool that is becoming increasingly important in the field of diagnostics, drug discovery, and biomanufacturing.

Information on NBRP:

NBRP is committed to creating an innovative biomedical ecosystem, connecting high-quality basic research forward, capturing the commercial field backward, implementing chemical research for use, and integrating industry, government, academia and research to promote the development of Taiwan's biotechnology innovation. The resources of the department assist the product development and preclinical trials of biotechnology innovations and provide necessary assistance in a timely manner to cross the valley of death.